1Chen CM. Eating patterns--a prognosis for China. Asia Pac J Clin Nutr, 1995,4 Suppl 1:24-28.
2Wang Y, Mi J, Shan XY, et al. Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China. Int J Obes (Lond) , 2007,31:177-188.
3Barth RJ. Insulin resistance, obesity and the metabolic syndrome. S D Med, 2011 ,Spec No:22-27.
4Pou KM, Massaro JM, Hoffmann U, et al. Patterns of abdominal fat distribution: the Framingham Heart Study. Diabetes Care, 2009,32:481-485.
5Tran TT, Yamamoto Y, Gesta S, et al. Beneficial effects of subcutaneous fat transplantation on metabolism. Cell Metab, 2008,7:410-420.
6Miyazaki Y, Mahankali A, Matsuda M, et al. Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients. J Clin Endocrinol Metab, 2002, 87: 2784-2791.
7Kim SH, Reaven G. Obesity and insulin resistance: an ongoing saga. Diabetes, 2010,59:2105-2106.
8Waki H, Tontonoz P. Endocrine functions of adipose tissue. Annu Rev Pathol, 2007,2: 31-56.
9Okuno A, Tamemoto H, Tobe K, et al. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J Clin Invest, 1998, 101: 1354-1361.
10Nystrom FH, Chen H, Cong LN, et al. Caveolin-1 interacts with the insulin receptor and can differentially modulate insulin signaling in transfected Cos-7 cells and rat adipose cells. Mol Endocfinol, 1999,13:2013-2024.
